Rhythm Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 33 U.S.-traded ETFs. RYTM has around 2.7M shares in the U.S. ETF market. The largest ETF holder of RYTM is the iShares Russell 2000 ETF (IWM), with approximately 717.04K shares. Investors may also find of interest that the ETF with the largest allocation to RYTM stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 1.00%. On average, U.S. ETFs allocate 0.12% of RYTM to their portfolios.
Additionally, RYTM is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RYTM as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 55.60%.